Martin Demarchi

1.6k total citations
42 papers, 687 citations indexed

About

Martin Demarchi is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Martin Demarchi has authored 42 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 11 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Martin Demarchi's work include Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (10 papers) and Colorectal Cancer Treatments and Studies (8 papers). Martin Demarchi is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (10 papers) and Colorectal Cancer Treatments and Studies (8 papers). Martin Demarchi collaborates with scholars based in France, United States and Australia. Martin Demarchi's co-authors include Xavier Pivot, Christophe Borg, Thierry Nguyen, Cristian Villanueva, Carolina Lourencetti, Márcio Garcia Ribeiro, Antoine Thiery-Vuillemin, Stéfano Kim, L. Chaigneau and Fernando Bazán and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Martin Demarchi

42 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Demarchi France 15 314 162 151 128 118 42 687
Biswajit Dubashi India 15 268 0.9× 98 0.6× 115 0.8× 60 0.5× 117 1.0× 131 883
Jun Ye China 18 138 0.4× 188 1.2× 74 0.5× 87 0.7× 235 2.0× 64 1.1k
Rupen Shah United States 12 244 0.8× 353 2.2× 127 0.8× 86 0.7× 107 0.9× 33 767
Sachin Shah United States 13 286 0.9× 54 0.3× 172 1.1× 57 0.4× 211 1.8× 25 737
Glenn O. Allen United States 19 354 1.1× 84 0.5× 168 1.1× 131 1.0× 349 3.0× 59 1.1k
Juli Rifà Spain 17 602 1.9× 240 1.5× 237 1.6× 262 2.0× 196 1.7× 36 1.2k
Syed Hasan Raza Jafri United States 11 349 1.1× 63 0.4× 188 1.2× 88 0.7× 137 1.2× 29 860
Brigitte Tranchand France 22 556 1.8× 132 0.8× 152 1.0× 95 0.7× 276 2.3× 50 1.2k
Diamantis I. Tsilimigras United States 15 322 1.0× 185 1.1× 177 1.2× 144 1.1× 149 1.3× 56 982
Keigo Ashida Japan 21 629 2.0× 400 2.5× 309 2.0× 154 1.2× 192 1.6× 63 1.2k

Countries citing papers authored by Martin Demarchi

Since Specialization
Citations

This map shows the geographic impact of Martin Demarchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Demarchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Demarchi more than expected).

Fields of papers citing papers by Martin Demarchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Demarchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Demarchi. The network helps show where Martin Demarchi may publish in the future.

Co-authorship network of co-authors of Martin Demarchi

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Demarchi. A scholar is included among the top collaborators of Martin Demarchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Demarchi. Martin Demarchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erb, Stéphane, Hélène Diemer, Martin Demarchi, et al.. (2023). Influence of pneumatic transportation on the stability of monoclonal antibodies. Scientific Reports. 13(1). 21875–21875. 9 indexed citations
2.
Demarchi, Martin, et al.. (2023). Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A Systematic Review. Cancers. 15(20). 4940–4940. 1 indexed citations
3.
Lecointre, Lise, Lobna Ouldamer, Sofiane Bendifallah, et al.. (2021). Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group. Annals of Surgical Oncology. 28(12). 7616–7623. 7 indexed citations
4.
5.
6.
Royer, Bernard, Antonin Schmitt, Thierry Nguyen, et al.. (2020). Exposure‐response analysis of Raltitrexed assessing liver toxicity. British Journal of Clinical Pharmacology. 87(3). 1327–1337. 4 indexed citations
7.
Schött, Roland, Thierry Petit, Martin Demarchi, et al.. (2020). Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol. Frontiers in Oncology. 10. 1304–1304. 7 indexed citations
8.
Deplanque, G., Martin Demarchi, Mohamed Hebbar, et al.. (2015). A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer. Annals of Oncology. 26(6). 1194–1200. 78 indexed citations
9.
Fiteni, Frédéric, Marine Jary, Franck Monnien, et al.. (2014). Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy. BMC Gastroenterology. 14(1). 143–143. 19 indexed citations
10.
Kim, Stéfano, Marine Jary, Luigi Mansi, et al.. (2013). DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma. Annals of Oncology. 24(12). 3045–3050. 32 indexed citations
11.
Romieu, Gilles, J Salvat, L. Chaigneau, et al.. (2013). Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer—Study BES 06. Targeted Oncology. 8(2). 137–143. 9 indexed citations
12.
13.
Dobi, Erion, Franck Monnien, Stéfano Kim, et al.. (2012). Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 12(1). 28–36. 34 indexed citations
14.
Dobi, Erion, Fernando Bazán, Armelle Dufresne, et al.. (2012). Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?. International Journal of Clinical Oncology. 18(4). 607–613. 14 indexed citations
15.
Villanueva, Cristian, L. Chaigneau, Armelle Dufresne, et al.. (2011). Phase II trial of paclitaxel and uracil–tegafur in metastatic breast cancer. TEGATAX trial. The Breast. 20(4). 329–333. 1 indexed citations
16.
17.
Thiery-Vuillemin, Antoine, Erion Dobi, Thierry Nguyen, et al.. (2010). Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors. Anti-Cancer Drugs. 21(10). 958–962. 3 indexed citations
18.
Guardiola, Emmanuel, Bruno Chauffert, Delphine Delroeux, et al.. (2010). Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study. Anti-Cancer Drugs. 21(3). 320–325. 11 indexed citations
19.
Thiery-Vuillemin, Antoine, L. Chaigneau, N. Méaux-Ruault, et al.. (2008). Anticancer therapy in patients with porphyrias: evidence today. Expert Opinion on Drug Safety. 7(2). 159–165. 2 indexed citations
20.
Lourencetti, Carolina, Martin Demarchi, & Márcio Garcia Ribeiro. (2008). Determination of sugar cane herbicides in soil and soil treated with sugar cane vinasse by solid-phase extraction and HPLC-UV. Talanta. 77(2). 701–709. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Biswajit Dubashi Breakdown of academic impact, for papers by Jun Ye Breakdown of academic impact, for papers by Rupen Shah Breakdown of academic impact, for papers by Sachin Shah Breakdown of academic impact, for papers by Glenn O. Allen Breakdown of academic impact, for papers by Juli Rifà Breakdown of academic impact, for papers by Syed Hasan Raza Jafri Breakdown of academic impact, for papers by Brigitte Tranchand Breakdown of academic impact, for papers by Diamantis I. Tsilimigras Breakdown of academic impact, for papers by Keigo Ashida
Rankless by CCL
2026